Skip to content

Clinical trials

Phase 2 Disorders of Excessive Somnolence trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Disorders of Excessive Somnolence Phase: Phase 2 Clear all

25 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20071
20081
20091
20102
20141
20162
20172
20192
20213
20221
20245
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed19
Recruiting3
Active, not recruiting1
Terminated1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Jazz Pharmaceuticals3
Alkermes, Inc.2
Bioprojet2
Duke University2
Axsome Therapeutics, Inc.1
Baylor College of Medicine1
BenevolentAI Bio1
Centessa Pharmaceuticals (UK) Limited1
Christian Baumann1
Harmony Biosciences Management, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Disorders of Excessive Somnolence25
Narcolepsy8
Parkinson Disease6
Idiopathic Hypersomnia5
Sleep Wake Disorders4
Sleep Apnea, Obstructive3
Cataplexy2
Parasomnias2
Post-Acute COVID-19 Syndrome2
Fatigue1

Trials

Showing 1 to 25 of 25. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.